{
  "hits": [
    {
      "_id": "2021-A01563-38",
      "_index": "eclaire",
      "_score": 1,
      "_source": {
        "category": [
          {
            "coding": [
              {
                "code": "REG745",
                "display": "REG745 (DM)",
                "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-regulation-code-code-system",
                "version": "0.3.0",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "IC-Cas-4-2",
                "display": "IC-Cas 4.2 (DM)",
                "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-reglementation-precision-code-system",
                "version": "0.3.0",
              },
            ],
          },
        ],
        "contact": [
          {
            "extension": [
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-name",
                "valueHumanName": {
                  "given": [],
                  "use": "official",
                },
              },
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-type",
                "valueCodeableConcept": {
                  "coding": [
                    {
                      "code": "PUB",
                      "display": "Publique / Public",
                      "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-type-contact-code-system",
                      "version": "0.3.0",
                    },
                  ],
                },
              },
            ],
            "telecom": [
              {
                "system": "phone",
                "use": "work",
              },
              {
                "system": "email",
                "use": "work",
              },
            ],
          },
        ],
        "enrollment": [
          {
            "display": "Reference to group detailing study characteristics",
            "reference": "Group/2021-A01563-38-enrollment-group",
            "type": "Group",
          },
        ],
        "extension": [
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-review-date",
            "valueInstant": "2023-04-06T00:00:00.000Z",
          },
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-therapeutic-area",
            "valueString": "Hépato-gastro-entérologie",
          },
          {
            "extension": [
              {
                "url": "name",
                "valueString": "Soladis Clinical Studies",
              },
              {
                "url": "role",
                "valueCodeableConcept": {
                  "coding": [
                    {
                      "code": "lead-sponsor",
                      "display": "lead-sponsor",
                      "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-party-role-code-system",
                      "version": "0.3.0",
                    },
                  ],
                },
              },
              {
                "url": "party",
                "valueReference": {
                  "display": "Reference to primary sponsor",
                  "reference": "Organization/2021-A01563-38-primary-sponsor",
                  "type": "Organization",
                },
              },
            ],
            "url": "http://hl7.org/fhir/5.0/StructureDefinition/extension-ResearchStudy.associatedParty",
          },
        ],
        "id": "2021-A01563-38",
        "identifier": [
          {
            "assigner": {
              "display": "Reference to primary assigner",
              "reference": "Organization/ansm",
              "type": "Organization",
            },
            "use": "official",
            "value": "2021-A01563-38",
          },
        ],
        "meta": {
          "lastUpdated": "2023-04-06T00:00:00.000Z",
          "profile": [
            "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-researchstudy",
          ],
        },
        "phase": {
          "coding": [
            {
              "code": "n-a",
              "display": "N/A",
              "system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
              "version": "1.0.0",
            },
          ],
        },
        "resourceType": "ResearchStudy",
        "status": "administratively-completed",
        "text": {
          "div": "<div xmlns="http://www.w3.org/1999/xhtml"><h2>Données reçues avant modélisation FHIR</h2><ul><li> reglementation_code: REG745 </li><li> precision_reglementation: IC-Cas 4.2 </li><li> etat: TERMINEE_ANTICIPEE </li><li> organisme_nom: Soladis Clinical Studies </li><li> organisme_adresse: 15 Boulevard du Général Leclerc </li><li> organisme_code_postal: 59100 </li><li> organisme_pays: France </li><li> organisme_ville: Roubaix </li><li> contact_nom: null </li><li> contact_prenom: null </li><li> contact_telephone: null </li><li> contact_courriel: null </li><li> sites: Organisme: null - Adresse: null - Ville: null - Titre: null - Nom: null - Prenom: null - Service: null </li><li> numero_primaire: 2021-A01563-38 </li><li> titre: ÉVALUATION DU DISPOSITIF MEDICAL ENDOTRAP POUR LA PROTECTION DU PERSONNEL DU BLOC OPERATOIRE CONTRE LES PARTICULES MICROBIENNES PENDANT L'ENDOSCOPIE DIGESTIVE HAUTE  </li><li> phase_recherche: N/A </li><li> domaine_therapeutique: Hépato-gastro-entérologie </li><li> pathologies_maladies_rares: null </li><li> informations_meddra: undefined </li><li> taille_etude: 96 </li><li> tranches_age: undefined </li><li> sexe: unknown </li><li> groupes_sujet: null </li><li> population_recrutement:  </li><li> date_debut_recrutement: null </li><li> historique: 2023-04-06:Terminée </li><li> dates_avis_favorable_ms_mns: 21.01155.000011-MS01:2021-11-09, 21.01155.000011-MS02:2022-03-09, 21.01155.000011-MS03:2022-10-04, 21.01155.000011-MS04.1:2022-11-29 </li><li> pays_concernes: undefined </li><li> date_theorique_maximale_autorisation_cpp: 2023-04-23 </li><li> contact_public: Nom: null - Prenom: null Courriel: null Tel: null </li><li> criteres_eligibilite: Titre: null - Type: null,Titre: TEST INCLUSION - Type: INCLUSION,Titre: TEST EXCLUSION - Type: EXCLUSION </li><li> criteres_jugement: Titre: null - Type: null,Titre: TEST PRINCIPAL - Type: PRINCIPAL,Titre: TEST SECONDAIRE - Type: SECONDAIRE </li><li> objectifs: null </li><li> resume: null </li><li> statut_recrutement: Recrutement en attente </li><li> date_fin_recrutement: null </li></ul></div>",
          "status": "extensions",
        },
        "title": "ÉVALUATION DU DISPOSITIF MEDICAL ENDOTRAP POUR LA PROTECTION DU PERSONNEL DU BLOC OPERATOIRE CONTRE LES PARTICULES MICROBIENNES PENDANT L'ENDOSCOPIE DIGESTIVE HAUTE ",
      },
      "_type": "_doc",
    },
    {
      "_id": "2021-A01022-39",
      "_index": "eclaire",
      "_score": 1,
      "_source": {
        "category": [
          {
            "coding": [
              {
                "code": "JARDE",
                "display": "JARDE (Jarde)",
                "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-regulation-code-code-system",
                "version": "0.3.0",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "cat3-jarde",
                "display": "Catégorie 3 (JARDE)",
                "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-reglementation-precision-code-system",
                "version": "0.3.0",
              },
            ],
          },
        ],
        "contact": [
          {
            "extension": [
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-name",
                "valueHumanName": {
                  "given": [],
                  "use": "official",
                },
              },
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-type",
                "valueCodeableConcept": {
                  "coding": [
                    {
                      "code": "PUB",
                      "display": "Publique / Public",
                      "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-type-contact-code-system",
                      "version": "0.3.0",
                    },
                  ],
                },
              },
            ],
            "telecom": [
              {
                "system": "phone",
                "use": "work",
              },
              {
                "system": "email",
                "use": "work",
              },
            ],
          },
        ],
        "enrollment": [
          {
            "display": "Reference to group detailing study characteristics",
            "reference": "Group/2021-A01022-39-enrollment-group",
            "type": "Group",
          },
        ],
        "extension": [
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-review-date",
            "valueInstant": "2023-04-04T00:00:00.000Z",
          },
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-therapeutic-area",
            "valueString": "Autres",
          },
          {
            "extension": [
              {
                "url": "name",
                "valueString": "Université Polytechnique Hauts-de-France",
              },
              {
                "url": "role",
                "valueCodeableConcept": {
                  "coding": [
                    {
                      "code": "lead-sponsor",
                      "display": "lead-sponsor",
                      "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-party-role-code-system",
                      "version": "0.3.0",
                    },
                  ],
                },
              },
              {
                "url": "party",
                "valueReference": {
                  "display": "Reference to primary sponsor",
                  "reference": "Organization/2021-A01022-39-primary-sponsor",
                  "type": "Organization",
                },
              },
            ],
            "url": "http://hl7.org/fhir/5.0/StructureDefinition/extension-ResearchStudy.associatedParty",
          },
        ],
        "id": "2021-A01022-39",
        "identifier": [
          {
            "assigner": {
              "display": "Reference to primary assigner",
              "reference": "Organization/ansm",
              "type": "Organization",
            },
            "use": "official",
            "value": "2021-A01022-39",
          },
        ],
        "meta": {
          "lastUpdated": "2023-04-04T00:00:00.000Z",
          "profile": [
            "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-researchstudy",
          ],
        },
        "phase": {
          "coding": [
            {
              "code": "phase-1",
              "display": "Phase 1",
              "system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
              "version": "1.0.0",
            },
          ],
        },
        "resourceType": "ResearchStudy",
        "status": "active",
        "text": {
          "div": "<div xmlns="http://www.w3.org/1999/xhtml"><h2>Données reçues avant modélisation FHIR</h2><ul><li> reglementation_code: JARDE </li><li> precision_reglementation: Catégorie 3 </li><li> etat: EN_COURS </li><li> organisme_nom: Université Polytechnique Hauts-de-France </li><li> organisme_adresse: LAMIH - Campus du Mont-Houy </li><li> organisme_code_postal: 59313 </li><li> organisme_pays: France </li><li> organisme_ville: Valenciennes </li><li> contact_nom: null </li><li> contact_prenom: null </li><li> contact_telephone: null </li><li> contact_courriel: null </li><li> sites: Organisme: null - Adresse: null - Ville: null - Titre: null - Nom: null - Prenom: null - Service: null </li><li> numero_primaire: 2021-A01022-39 </li><li> titre: Détermination des paramètres biomécaniques et fonctionnels de la locomotion des enfants en fonction des conditions de chaussage. </li><li> phase_recherche: Phase I </li><li> domaine_therapeutique: Autres </li><li> pathologies_maladies_rares: null </li><li> informations_meddra: undefined </li><li> taille_etude: 23 </li><li> tranches_age: undefined </li><li> sexe: unknown </li><li> groupes_sujet: null </li><li> population_recrutement:  </li><li> date_debut_recrutement: null </li><li> historique: 2023-04-04:En cours </li><li> dates_avis_favorable_ms_mns: 20.00002.210204-MS02:2021-07-29, 20.00002.210204-MS03:2021-10-26, 20.00002.210204-MS04:2023-01-26 </li><li> pays_concernes: undefined </li><li> date_theorique_maximale_autorisation_cpp: 2023-04-30 </li><li> contact_public: Nom: null - Prenom: null Courriel: null Tel: null </li><li> criteres_eligibilite: Titre: null - Type: null </li><li> criteres_jugement: Titre: null - Type: null </li><li> objectifs: null </li><li> resume: null </li><li> statut_recrutement: Recrutement en attente </li><li> date_fin_recrutement: null </li></ul></div>",
          "status": "extensions",
        },
        "title": "Détermination des paramètres biomécaniques et fonctionnels de la locomotion des enfants en fonction des conditions de chaussage.",
      },
      "_type": "_doc",
    },
    {
      "_id": "2024-500014-26-99",
      "_index": "eclaire",
      "_score": 1,
      "_source": {
        "category": [
          {
            "coding": [
              {
                "code": "REG536",
                "display": "REG536 (CTIS)",
                "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-regulation-code-code-system",
                "version": "0.3.0",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "study-ctis",
                "display": "un essai clinique (CTIS)",
                "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-reglementation-precision-code-system",
                "version": "0.3.0",
              },
            ],
          },
        ],
        "condition": [
          {
            "id": "disease-condition-2024-500014-26-99",
            "text": "Locally-Advanced or Metastatic breast cancer (MBC)",
          },
          {
            "coding": [
              {
                "code": "10070575",
                "display": "Cancer du sein à récepteurs aux oestrogènes positifs",
                "system": "https://www.meddra.org",
                "version": "3.0.0",
              },
            ],
            "id": "meddra-condition-2024-500014-26-99-10070575",
          },
          {
            "coding": [
              {
                "code": "10065430",
                "display": "Cancer du sein HER2 positif",
                "system": "https://www.meddra.org",
                "version": "3.0.0",
              },
            ],
            "id": "meddra-condition-2024-500014-26-99-10065430",
          },
        ],
        "contact": [
          {
            "extension": [
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-name",
                "valueHumanName": {
                  "family": "Trial Information Support Line-TISL, Switzerland",
                  "given": [
                    "Head of EU",
                  ],
                  "use": "official",
                },
              },
            ],
            "telecom": [
              {
                "system": "phone",
                "use": "work",
                "value": "0041616881111",
              },
              {
                "system": "email",
                "use": "work",
                "value": "global.rochegenentechtrials@roche.com",
              },
            ],
          },
          {
            "extension": [
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-name",
                "valueHumanName": {
                  "given": [],
                  "use": "official",
                },
              },
              {
                "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-contact-type",
                "valueCodeableConcept": {
                  "coding": [
                    {
                      "code": "PUB",
                      "display": "Publique / Public",
                      "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-type-contact-code-system",
                      "version": "0.3.0",
                    },
                  ],
                },
              },
            ],
            "telecom": [
              {
                "system": "phone",
                "use": "work",
              },
              {
                "system": "email",
                "use": "work",
              },
            ],
          },
        ],
        "enrollment": [
          {
            "display": "Reference to group detailing study characteristics",
            "reference": "Group/2024-500014-26-99-enrollment-group",
            "type": "Group",
          },
        ],
        "extension": [
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-review-date",
            "valueInstant": "2024-01-06T00:00:00.000Z",
          },
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-therapeutic-area",
            "valueString": "Diseases [C] - Neoplasms [C04]",
          },
          {
            "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-recruitment-period",
            "valuePeriod": {
              "start": "2022-06-30T00:00:00.000Z",
            },
          },
          {
            "extension": [
              {
                "url": "name",
                "valueString": "F. Hoffmann-La Roche AG",
              },
              {
                "url": "role",
                "valueCodeableConcept": {
                  "coding": [
                    {
                      "code": "lead-sponsor",
                      "display": "lead-sponsor",
                      "system": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-party-role-code-system",
                      "version": "0.3.0",
                    },
                  ],
                },
              },
              {
                "url": "party",
                "valueReference": {
                  "display": "Reference to primary sponsor",
                  "reference": "Organization/2024-500014-26-99-primary-sponsor",
                  "type": "Organization",
                },
              },
            ],
            "url": "http://hl7.org/fhir/5.0/StructureDefinition/extension-ResearchStudy.associatedParty",
          },
        ],
        "id": "2024-500014-26-99",
        "identifier": [
          {
            "assigner": {
              "display": "Reference to primary assigner",
              "reference": "Organization/ctis",
              "type": "Organization",
            },
            "use": "official",
            "value": "2024-500014-26-99",
          },
        ],
        "location": [
          {
            "coding": [
              {
                "code": "BE",
                "display": "Belgium",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "DE",
                "display": "Germany",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "ES",
                "display": "Spain",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "FR",
                "display": "France",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "HU",
                "display": "Hungary",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "IT",
                "display": "Italy",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "PL",
                "display": "Poland",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
          {
            "coding": [
              {
                "code": "PT",
                "display": "Portugal",
                "system": "urn:iso:std:iso:3166",
                "version": "4.0.1",
              },
            ],
          },
        ],
        "meta": {
          "lastUpdated": "2024-01-06T00:00:00.000Z",
          "profile": [
            "https://interop.esante.gouv.fr/ig/fhir/eclaire/StructureDefinition/eclaire-researchstudy",
          ],
        },
        "originalContentsToEnhance": {
          "meddraCodes": [
            "10070575",
            "10065430",
          ],
        },
        "phase": {
          "coding": [
            {
              "code": "phase-3",
              "display": "Phase 3",
              "system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
              "version": "1.0.0",
            },
          ],
        },
        "resourceType": "ResearchStudy",
        "site": [
          {
            "display": "Reference to site",
            "reference": "Location/2024-500014-26-99-0-site",
            "type": "Location",
          },
        ],
        "status": "active",
        "text": {
          "div": "<div xmlns="http://www.w3.org/1999/xhtml"><h2>Données reçues avant modélisation FHIR</h2><ul><li> reglementation_code: REG536 </li><li> precision_reglementation: un essai clinique (CTIS) </li><li> etat: EN_COURS </li><li> organisme_nom: F. Hoffmann-La Roche AG </li><li> organisme_adresse: Grenzacherstrasse 124 </li><li> organisme_code_postal: 4058 </li><li> organisme_pays: Switzerland </li><li> organisme_ville: Basel Town </li><li> contact_nom: Trial Information Support Line-TISL, Switzerland </li><li> contact_prenom: Head of EU </li><li> contact_telephone: 0041616881111 </li><li> contact_courriel: global.rochegenentechtrials@roche.com </li><li> sites: Organisme: Donnée non disponible - Adresse: Avenue Eugene Avinee - Ville: Lille - Titre: Dr. - Nom: Aumar - Prenom: Madeleine - Service: Gastroenterology Hepatology and Nutrition Unit Paediatric clinic, Child Unit </li><li> numero_primaire: 2024-500014-26-99 </li><li> titre: A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER </li><li> phase_recherche: Phase III </li><li> domaine_therapeutique: Diseases [C] - Neoplasms [C04] </li><li> pathologies_maladies_rares: Locally-Advanced or Metastatic breast cancer (MBC) </li><li> informations_meddra: 10070575,10065430 </li><li> taille_etude: 21 </li><li> tranches_age: 65+ years,18-64 years </li><li> sexe: Male,Female </li><li> groupes_sujet: Données non disponible </li><li> population_recrutement: Women of child bearing potential not using contraception,Women of child bearing potential using contraception </li><li> date_debut_recrutement: 2022-06-30T00:00:00.000Z </li><li> historique: 2024-01-06: En cours </li><li> dates_avis_favorable_ms_mns: 22.00800.000094-SM-1:2022-11-07, 22.00800.000094-SM-2:2024-01-06 </li><li> pays_concernes: BE,DE,ES,FR,HU,IT,PL,PT </li><li> date_theorique_maximale_autorisation_cpp: 2023-03-15 </li><li> contact_public: Nom: null - Prenom: null Courriel: null Tel: null </li><li> criteres_eligibilite: Titre: null - Type: null,Titre: TEST INCLUSION - Type: INCLUSION,Titre: TEST EXCLUSION - Type: EXCLUSION </li><li> criteres_jugement: Titre: null - Type: null,Titre: TEST PRINCIPAL - Type: PRINCIPAL,Titre: TEST SECONDAIRE - Type: SECONDAIRE </li><li> objectifs: null </li><li> resume: null </li><li> statut_recrutement: Recrutement en attente </li><li> date_fin_recrutement: null </li></ul></div>",
          "status": "extensions",
        },
        "title": "A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER",
        "translatedContent": {
          "diseaseCondition": "[Traduction locale] Locally-Advanced or Metastatic breast cancer (MBC)",
          "therapeuticArea": "[Traduction locale] Diseases [C] - Neoplasms [C04]",
          "title": "[Traduction locale] A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO+TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER",
        },
      },
      "_type": "_doc",
    },
  ],
  "total": 3,
}